Form 4: Chemed Corp Executive Michael Witzeman Reports Stock Transactions Following PSU Vesting

VP & Chief Financial Officer of Chemed Corp, Michael D. Witzeman, reports acquisition and disposal of Chemed Capital Stock following the vesting of Performance Stock Units (PSUs).

Summary

• Michael D. Witzeman, VP & Chief Financial Officer of Chemed Corp, filed a Form 4 detailing changes in beneficial ownership of Chemed Capital Stock on February 14, 2025.
• The transactions involve the vesting of Performance Stock Units (PSUs) based on the company's performance between January 1, 2022, and December 31, 2024.
• 652 PSUs vested based on the Company's cumulative adjusted earnings per share, exceeding the maximum payout threshold and yielding an award of 202.0% of target.
• 198 PSUs vested based on the Company's relative total shareholder returns, ranking in the 31.3 percentile of a peer group, yielding an award of 61.0% of target.
• 276 shares were withheld to satisfy tax obligations related to the vesting of PSUs.
• Witzeman also acquired 1,128 PSUs that will vest based on performance targets from January 1, 2025, to December 31, 2027.
• Following these transactions, Witzeman directly owns 4,358 shares of Chemed Capital Stock and 2,736 Performance Stock Units.

Sentiment

Score: 7

Explanation: The document indicates positive performance related to earnings per share and shareholder returns, leading to PSU vesting. The granting of new PSUs also suggests confidence in future performance. However, the withholding of shares for tax obligations is a minor negative.

Positives

• The vesting of PSUs indicates that the company achieved certain performance targets related to earnings per share and shareholder returns.
• The company's cumulative adjusted earnings per share exceeded the maximum payout threshold, resulting in a 202.0% payout for a portion of the PSUs.
• The granting of new PSUs for the period 2025-2027 suggests continued confidence in the company's future performance.

Negatives

• Shares were withheld to cover tax obligations, reducing the number of shares directly received by the reporting person.

Risks

• Future PSU vesting is contingent on the company achieving specific performance targets, which may not be met.
• Changes in tax laws could impact the value of vested shares and the amount withheld for tax obligations.

Future Outlook

The company granted new PSUs that will vest based on performance targets from January 1, 2025, to December 31, 2027, suggesting continued focus on achieving specific financial goals.

Industry Context

Executive compensation in publicly traded companies often includes stock-based awards like PSUs to align management's interests with those of shareholders. Vesting is typically tied to performance metrics, incentivizing executives to achieve specific financial goals.

Comparison to Industry Standards

• PSUs are a common form of executive compensation in publicly traded companies, including those in the healthcare sector like Chemed Corp.
• Companies like Amedisys and LHC Group also utilize performance-based equity awards to incentivize their executives.
• The specific performance metrics used for PSU vesting, such as adjusted earnings per share and relative total shareholder returns, are typical benchmarks used in the industry.

Stakeholder Impact

• Shareholders may view the PSU vesting as a positive sign, indicating that management is incentivized to achieve financial goals.
• Employees may be motivated by the company's performance and the potential for future PSU vesting.

Next Steps

• The performance level for the new PSUs granted in 2025 will be determined by March 15, 2028, and earned shares will be delivered thereafter.

Key Dates

Keywords

Chemed Corp, Michael Witzeman, Form 4, Performance Stock Units, PSU, Beneficial Ownership, Capital Stock, Insider Trading